member
Dr. San PUN
Founder & CEO, AiMorphous Health
Dr. San Pun is co founder of AiMorphous Health, a Swiss & hk healthtech startup developing breakthrough diagnostics to precisely assess thrombosis risk. A seasoned scientist, inventor, and product developer, he holds multiple patents and has published in top-tier journals. He translates rigorous research into scalable clinical solutions that enable earlier intervention and better outcomes. Driven to reduce preventable vascular events, Dr. Pun advances diagnostic science to empower clinicians, meaningfully save lives and advancing ESG & longevity.
Company Description
With a novel and unique early blood biomarker-algorithm duplex system, we overcome the current problems in early detection and lack of predictive value in the standard of care for thrombosis prevention and precision management. We have tested and proven the sensitivity and specificity of such biomarkers, and the risk model will be the most accurate and is capable of provide individualized risk estimation with high resolution. We have closed a pre-seed round and established the first-ever biomarker laboratory according to ISO 13485. Currently seeking seed financing to market assay kit and FDA regulatory approval early next year.